BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 11/13/20

BSTZ has been on fire, as it is invested in all the hot tech plays. The fund is paying out attractive monthly income, and shareholders just got a big boost in the amount too. BSTZ might have had an incredible run, but I don't think it is over yet. For further details see: ...

BMEZ is a fund that is focused on the healthcare space, more specifically, a focus on the health sciences industry. They overlay this healthcare strategy with an option writing strategy to potentially enhance income. The fund has done exceptionally well since its launch right befo...

Stimulus talks continue as the two parties try to hash out a deal before the elections.  That deal before November is becoming more elusive. The September payrolls report showed that 661K jobs were added in the month, which was below expectations of 850K.  Unemployment rate ...

A lot of CEFs have tech-related exposure; however, 4 of them are focused almost exclusively on tech. These funds could show some buying opportunities as tech heads into correction territory. Tech is still clearly stretched in valuation, though watching for opportunities in CEFs ca...

BlackRock Science and Technology Trust II (BSTZ) declares $0.115/share monthly dividend, 15% increase from prior dividend of $0.10.Forward yield 5.22%Payable Oct. 30; for shareholders of record Oct. 15; ex-div Oct. 14.See BSTZ Dividend Scorecard, Yield Chart, & Dividend Growth. For furt...

You know those technology stocks that have corrected 20% or more already.  Trying taking off another 11% to 13%.  Is that getting cheap enough for you? Then consider a value fund that just breached the 100% market price premium level.  Who in their right mind would buy ...

BlackRock Science And Technology Trust II ( BSTZ ) is a limited-term closed-end equity fund. BSTZ began operations in June 2019 with the investment objectives of providing total return and income through a combination of current income, current gains and long-term capital appreciation. Und...

Written by Nick Ackerman, co-produced by Stanford Chemist We last visited BlackRock Health Sciences Trust II ( BMEZ ) only a couple of months after its launch in January. Several months have passed, and this fund has been performing exceptionally well. While it has only been a few months...

Written by Nick Ackerman, co-produced by Stanford Chemist July was another solid month for the market as measured by the S&P 500 ETF ( SPY ), a barometer for the overall market. This is, of course, a continuation of the rebound from March's lows. Interestingly enough, for the month o...

Written by Nick Ackerman, co-produced by Stanford Chemist Recently, we took a position in BlackRock Science & Technology Trust II ( BSTZ ). This was in our Tactical Income-100 Portfolio. This portfolio is designed to be more aggressive and take advantage of special situations. In t...